Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Mosebach

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 8, 2018
Jennifer Mosebach, Sarah Haller, Maliha Sadick
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 29, 2019
Multiple Myeloma Guidelines and Their Recent Updates: Implications for ImagingJennifer Mosebach, Heidi Thierjung, Heinz-Peter Schlemmer, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 10, 2015
Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myelomaChristos Sachpekidis, Jens Hillengass, Hartmut Goldschmidt, et al.
Haematologica|December 9, 2017
Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantationJennifer Mosebach, Sofia Shah, Stefan Delorme, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 10, 2015
Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalitiesChristos Sachpekidis, Jennifer Mosebach, Martin T Freitag, et al.
Journal of Psychiatric Research|April 26, 2013
Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss?Jennifer Mosebach, Gerburg Keilhoff, Tomasz Gos, et al.
British Journal of Haematology|May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damageMarkus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 8, 2018
Jennifer Mosebach, Sarah Haller, Maliha Sadick
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 29, 2019
Multiple Myeloma Guidelines and Their Recent Updates: Implications for ImagingJennifer Mosebach, Heidi Thierjung, Heinz-Peter Schlemmer, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 10, 2015
Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myelomaChristos Sachpekidis, Jens Hillengass, Hartmut Goldschmidt, et al.
Haematologica|December 9, 2017
Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantationJennifer Mosebach, Sofia Shah, Stefan Delorme, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 10, 2015
Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalitiesChristos Sachpekidis, Jennifer Mosebach, Martin T Freitag, et al.
Journal of Psychiatric Research|April 26, 2013
Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss?Jennifer Mosebach, Gerburg Keilhoff, Tomasz Gos, et al.
British Journal of Haematology|May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damageMarkus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Pageof 1